Drug Approval | April 07, 2022
Lupin launches Merzee capsules in the United States
Merzee is a generic equivalent of Taytulla of Allergan Pharmaceuticals International
Merzee is a generic equivalent of Taytulla of Allergan Pharmaceuticals International
The new reagents will bring the exceptional sensitivity of the company’s liquid format 1-step RT-qPCR reagents to a freeze-dryable format
An upgraded, state-of-the-art integrated app, helps easy discovery of expert surgeons for convenient in-clinic or online consultation
The Blockchain-based solution was awarded the 2021 Bionow Technical Service Award
The partnership demonstrates increasing adoption of tetra data to create unrestricted innovation
Highlighted as game changer in drug development & delivery special feature on innovative technologies for improving drug solubility and bioavailability
Under the terms of the agreement, Vipergen will apply its in-living-cell DNA-encoded library (DEL) screening platform to discover novel small-molecule compounds that bind to a selected Theseus kinase target
Announces pilot project for rapid, remote diagnosis of tuberculosis
Highly prestigious award endowed with €500,000 to uphold the United Nations 2030 Agenda
It also secures US $ 10 million for US launch and commercialization
Subscribe To Our Newsletter & Stay Updated
